Send Inquiry

Request To Call Back

ESENTRA 120

Name: ESENTRA 120
Brand: Ezan Pharmaceuticals
Price: 10000 INR
Availability: InStock

Price 10000 INR/ Unit

Get a Price/Quote

MOQ : 1 Pack

ESENTRA 120 Specification

Life Span
24 months from manufacturing date

Salt Composition
Denosumab 60 mg

Packaging Type
Pre-filled syringe

Indication
Indicated for osteoporosis, bone metastases, prevention of skeletal related events

Pacakaging (Quantity Per Box)
1 syringe per box

Brand Name
Denosumab

Dosage Form
Injection

Origin of Medicine
Imported or Manufactured in India

Drug Type
Other

Ingredients
Denosumab

Physical Form
Liquid

Function
Other

Recommended For
Osteoporosis, bone loss conditions, cancer-related bone problems

Dosage
60 mg per injection or as prescribed by the physician

Dosage Guidelines
Administer as instructed by healthcare professionals, usually once every 6 months

Suitable For
Adults, Suitable For All

Quantity
1 pre-filled syringe

Storage Instructions
Store in a refrigerator (2C - 8C). Do not freeze.

Side Effects
May cause back pain, pain in extremity, hypercholesterolemia, urinary bladder infection

Route of Administration
Subcutaneous

Marketed By
Various pharmaceutical suppliers/distributors

Caution
Not for use in pediatric patients. Monitor for hypocalcemia.

ATC Code
M05BX04

Prescription Required
Yes

Brand Example
Prolia, Xgeva

Shelf Life After Opening
Use immediately after opening

Packing Material
Sterile packaging

Appearance
Clear to slightly opalescent, colorless to pale yellow solution

Volume per Syringe
1 mL

Patient Advice
Ensure adequate calcium and vitamin D intake during therapy

ESENTRA 120 Trade Information

Minimum Order Quantity
1 Pack

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
1 Days

Main Domestic Market
All India, Nagaland, Manipur, Meghalaya, Tripura, Sikkim, Assam, Mizoram, Arunachal Pradesh

About ESENTRA 120

Experience the renowned advantages of Denosumab Solution for Injection, a preeminent biologic now trending among advanced osteoporosis and cancer care therapies. This new release, available as Prolia or Xgeva, offers a personalised approach to preventing bone loss and increasing bone density. Manufactured and marketed by venerable pharmaceutical suppliers, each pre-filled syringe holds 1 mL of clear to slightly opalescent solution. With its remarkable efficacy, Denosumab 60 mg is indicated for osteoporosis, metastatic bone disease, and other bone-related conditions. Prescription required. Use only as directed by a healthcare professional.

Precision in Application and Versatility of Use

Denosumab Solution For Injection is specifically designed for subcutaneous administration with a state-of-the-art, pre-filled syringe. Its application caters to adults dealing with osteoporosis, cancer-related bone loss, or skeletal-related events. The clear, pre-sterilized packaging ensures safe delivery while the personalised dosage enables healthcare professionals to address unique patient needs. This trending biologic is recommended for use at healthcare facilities, ensuring optimal efficacy and adherence to safety protocols during every procedure.

Supply Capacity and Global Export Reach

With a robust supply ability, Denosumab Solution For Injection is readily available from trusted suppliers and traders in India. Samples can be made available for healthcare providers upon request. The main export markets include Asia, Africa, and the Middle East, with growing demand in North America and Europe. The market value of Denosumab continues to rise, with estimates reflecting its preeminent position among anti-osteoporotic therapies. Efficient logistics and stringent quality checks ensure timely, reliable deliveries.

FAQ's of Denosumab Solution For Injection:

Q: How should Denosumab Solution For Injection be administered?

A: Denosumab Solution For Injection is administered subcutaneously, usually once every six months, by a qualified healthcare professional. Follow the dosage and schedule prescribed by your physician.

Q: What conditions is Denosumab recommended for?

A: Denosumab is primarily indicated for osteoporosis, bone loss due to cancer, and prevention of skeletal-related events in adults. It is not intended for pediatric use.

Q: Where should Denosumab Solution For Injection be stored?

A: Store the injection in a refrigerator at 2C to 8C. Do not freeze. Use the solution immediately after opening to maintain its sterility and efficacy.

Q: When should a patient avoid Denosumab or be cautious?

A: Denosumab should not be used in pediatric patients. Caution is required in adults with low blood calcium levels (hypocalcemia), and calcium and vitamin D supplementation is strongly advised during therapy.

Q: What are the potential side effects of Denosumab Injection?

A: Some reported side effects include back pain, pain in the extremities, high cholesterol levels, and urinary bladder infection. Immediate medical attention is recommended if severe reactions occur.

Q: What benefits does Denosumab offer compared to traditional therapies?

A: Denosumab is a biologic that provides targeted prevention of bone loss and strengthening of bone density, making it a valuable option for high-risk patients, with less frequent dosing required compared to many conventional treatments.

Tell us about your requirement